Search - tctmd.com

Displaying 121 - 140 of 1300

Sort: Relevancy | Date

News Daily News

Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use

Michael O'Riordan

June 28, 2016

News Daily News

Aspirin App Pairs Clinical Studies With Technology to Balance Bleeding, Benefits

Michael H. Wilson

June 27, 2016

News Daily News

新分析质疑低密度脂蛋白胆固醇“越低越好”的说法，但专家仍呼吁应注意

Todd Neale

June 22, 2016

News Daily News

Un Nuevo Análisis Cuestiona el Mantra ‘Mejor Menos’, aunque los Expertos Piden Cautela

Todd Neale

June 22, 2016

News Daily News

‘Lower Is Better’ Mantra for LDL Cholesterol Questioned by New Analysis, but Experts Urge Caution

Todd Neale

June 22, 2016

News Daily News

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Yael L. Maxwell

June 20, 2016

Presentation

Effect of Post-PPCI Bivalirudin Infusion on Acute Stent Thrombosis: Meta-analysis of RCTs

Presenter: Rahman Shah

June 20, 2016

News Daily News

胆固醇治疗试验协作再次审视他汀类药物与不良事件之间的关系

Michael O'Riordan

June 13, 2016

News Daily News

Los Niveles de CRP Puede Identificar Riesgos CV Bajos en Pacientes Obesos Metabólicamente ‘Sanos’

L.A. McKeown

June 13, 2016

News Daily News

La Colaboración de Ensayistas para el Tratamiento del Colesterol Vuelve a Analizar los Episodios Adversos secundarios a las Estatinas

Michael O'Riordan

June 13, 2016

News Daily News

CRP 可以用于识别代谢“健康”的肥胖患者的低心血管风险

L.A. McKeown

June 13, 2016

News Daily News

CRP Can Identify Low CV Risk in Metabolically ‘Healthy’ Obese Patients

L.A. McKeown

June 13, 2016

News Daily News

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Michael O'Riordan

June 13, 2016

Presentation SOLACI 2016

Como selecionar o tipo de stent e antiplaquetários para cirurgias não cardíacas

Presenter: Miguel A N Rati

June 10, 2016

Presentation SOLACI 2016

The Unmet Needs of DES

Presenter: Roxana Mehran

June 09, 2016

Presentation SOLACI 2016

Drug-eluting Stent and Dual Platelet Aggregation: What We Must Know

Presenter: Eduardo Nagib

June 09, 2016

News Daily News

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Michael O'Riordan

June 09, 2016

Presentation SOLACI 2016

Adjunctive Pharmacology for Patients with ACS Treated Invasively

Presenter: Eric R. Bates

June 09, 2016

News Conference News EAS 2016

Non-HDL Cholesterol, Inflammation Appear to Be Linked in Patients Undergoing Elective PCI

Yael L. Maxwell

June 08, 2016

Presentation SOLACI 2016

Mitos e verdades sobre o uso de antiplaquetários na intervenção percutânea

Presenter: Roberto Esporcatte

June 08, 2016

Advertisement

Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use

Aspirin App Pairs Clinical Studies With Technology to Balance Bleeding, Benefits

新分析质疑低密度脂蛋白胆固醇“越低越好”的说法，但专家仍呼吁应注意

Un Nuevo Análisis Cuestiona el Mantra ‘Mejor Menos’, aunque los Expertos Piden Cautela

‘Lower Is Better’ Mantra for LDL Cholesterol Questioned by New Analysis, but Experts Urge Caution

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Effect of Post-PPCI Bivalirudin Infusion on Acute Stent Thrombosis: Meta-analysis of RCTs

胆固醇治疗试验协作再次审视他汀类药物与不良事件之间的关系

Los Niveles de CRP Puede Identificar Riesgos CV Bajos en Pacientes Obesos Metabólicamente ‘Sanos’

La Colaboración de Ensayistas para el Tratamiento del Colesterol Vuelve a Analizar los Episodios Adversos secundarios a las Estatinas

CRP 可以用于识别代谢“健康”的肥胖患者的低心血管风险

CRP Can Identify Low CV Risk in Metabolically ‘Healthy’ Obese Patients

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Como selecionar o tipo de stent e antiplaquetários para cirurgias não cardíacas

The Unmet Needs of DES

Drug-eluting Stent and Dual Platelet Aggregation: What We Must Know

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Adjunctive Pharmacology for Patients with ACS Treated Invasively

Non-HDL Cholesterol, Inflammation Appear to Be Linked in Patients Undergoing Elective PCI

Mitos e verdades sobre o uso de antiplaquetários na intervenção percutânea

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content